# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-021120
Filing Date
2024-05-07
Accepted
2024-05-07 16:23:58
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | xfor-20240331.htm iXBRL | 10-Q | 1139415
2 | EX-31.1 | ex-311q12024.htm | EX-31.1 | 9254
3 | EX-31.2 | ex-312q12024.htm | EX-31.2 | 9242
4 | EX-32.1 | ex-321q12024.htm | EX-32.1 | 5445
| Complete submission text file | 0001628280-24-021120.txt |  | 5910883

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | xfor-20240331.xsd | EX-101.SCH | 50242
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | xfor-20240331_cal.xml | EX-101.CAL | 55147
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | xfor-20240331_def.xml | EX-101.DEF | 212113
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | xfor-20240331_lab.xml | EX-101.LAB | 500916
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | xfor-20240331_pre.xml | EX-101.PRE | 365529
80 | EXTRACTED XBRL INSTANCE DOCUMENT | xfor-20240331_htm.xml | XML | 748967

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 24922370
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)